Compare $ACUT vs $DYAI | Chartloom

Compare

$ACUT vs $DYAI

Accustem Sciences Inc · Dyadic International Inc

ACUT

Accustem Sciences Inc

DYAI

Dyadic International Inc

Compare $ACUT vs $DYAI

Comparing Accustem Sciences Inc and Dyadic International Inc

ACUTAccustem Sciences Inc

DYAIDyadic International Inc

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

DYAIDyadic International Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.15x

Rev growth (TTM)

-8.1%

YTD performance

-52.8%

52W performance

-60.7%

FCF yield

-45.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

DYAI

Detailed metrics comparison

ACUT

Accustem Sciences Inc

DYAI

Dyadic International Inc

Market Cap

ACUT$2M

DYAI$16M

Enterprise Value

ACUT$2M

DYAI$20M

Price

ACUT$0.15

DYAI$0.44

P/E Ratio

ACUTN/A

DYAIN/A

P/S Ratio

ACUT0.00x

DYAI4.26x

EV/Sales

ACUT0.00x

DYAI5.21x

EV/EBITDA

ACUT0.00x

DYAI75.44x

P/B Ratio

ACUT2.97x

DYAI14.82x

P/FCF Ratio

ACUTN/A

DYAIN/A

EV/FCF

ACUT-2.01x

DYAI-2.67x

PEG Ratio

ACUTN/A

DYAIN/A

Forward P/E (NTM)

ACUTN/A

DYAIN/A

Forward P/S (NTM)

ACUTN/A

DYAI2.15x

Revenue (TTM)

ACUT$0

DYAI$4M

Revenue Growth (YoY)

ACUTN/A

DYAI-8.1%

Forward Rev Growth

ACUT0.0%

DYAI91.1%

Gross Margin (TTM)

ACUT0.0%

DYAI16.2%

Operating Margin (TTM)

ACUT0.0%

DYAI0.0%

EBITDA Margin (TTM)

ACUT0.0%

DYAI-194.5%

Net Margin (TTM)

ACUT0.0%

DYAI-200.5%

FCF Margin (TTM)

ACUTN/A

DYAI-194.7%

Net Income (TTM)

ACUT$-2M

DYAI$-8M

FCF (TTM)

ACUT$-1M

DYAI$-7M

EPS (TTM)

ACUT-$0.10

DYAI-$0.21

ROE (TTM)

ACUT-21712.9%

DYAI-35086.0%

ROA (TTM)

ACUT-10530.0%

DYAI-8477.0%

ROIC (TTM)

ACUT-179413.5%

DYAI-8444.0%

Cash

ACUT$13K

DYAI$1M

Debt

ACUT$63K

DYAI$5M

Net Cash/Debt

ACUT$-50K

DYAI$-4M

Current Ratio (TTM)

ACUT0.02x

DYAI1.65x

Quick Ratio (TTM)

ACUT0.00x

DYAI1.54x

Debt/Equity (TTM)

ACUT0.27x

DYAI4.08x

Debt/Assets (TTM)

ACUT0.0%

DYAI0.0%

Interest Coverage (TTM)

ACUTN/A

DYAIN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

DYAI0.00x

Beta

ACUT1.88

DYAI1.09

52W Performance

ACUT-67.3%

DYAI-60.7%

YTD Performance

ACUT-75.6%

DYAI-52.8%

% from 52W High

ACUT-93.7%

DYAI-72.2%

% from 52W Low

ACUT26.0%

DYAI30.6%

Asset Turnover (TTM)

ACUT0.00x

DYAI0.42x

FCF Yield (TTM)

ACUT-50.9%

DYAI-45.8%

Earnings Yield (TTM)

ACUT-69.8%

DYAI-47.1%

Dividend Yield (TTM)

ACUTN/A

DYAIN/A

Rule of 40

ACUT0.0

DYAI-202.8

EV/GP/RG

ACUTN/A

DYAI0.30

Ticker research

View ACUT research View DYAI research

Metric	ACUT Accustem Sciences Inc	DYAI Dyadic International Inc
Market & Valuation
Market Cap	$2M	$16M
Enterprise Value	$2M	$20M
Price	$0.15	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.26x
EV/Sales	0.00x	5.21x
EV/EBITDA	0.00x	75.44x
P/B Ratio	2.97x	14.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-2.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.15x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	-8.1%
Forward Rev Growth	0.0%	91.1%
Profitability
Gross Margin (TTM)	0.0%	16.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-194.5%
Net Margin (TTM)	0.0%	-200.5%
FCF Margin (TTM)	N/A	-194.7%
Net Income (TTM)	$-2M	$-8M
FCF (TTM)	$-1M	$-7M
EPS (TTM)	-$0.10	-$0.21
ROE (TTM)	-21712.9%	-35086.0%
ROA (TTM)	-10530.0%	-8477.0%
ROIC (TTM)	-179413.5%	-8444.0%
Financial Health
Cash	$13K	$1M
Debt	$63K	$5M
Net Cash/Debt	$-50K	$-4M
Current Ratio (TTM)	0.02x	1.65x
Quick Ratio (TTM)	0.00x	1.54x
Debt/Equity (TTM)	0.27x	4.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	1.09
52W Performance	-67.3%	-60.7%
YTD Performance	-75.6%	-52.8%
% from 52W High	-93.7%	-72.2%
% from 52W Low	26.0%	30.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.42x
FCF Yield (TTM)	-50.9%	-45.8%
Earnings Yield (TTM)	-69.8%	-47.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-202.8
EV/GP/RG	N/A	0.30
Ticker research	View ACUT research	View DYAI research

Valuation

P/S Ratio

ACUT

0.00x

DYAI

4.26x

EV/FCF

DYAI

-2.67x

ACUT

-2.01x

Growth & revenue

Revenue Growth TTM

DYAI

-8.1%

Forward Revenue Growth

DYAI

91.1%

ACUT

0.0%

Profitability & performance

Gross Margin

DYAI

16.2%

ACUT

0.0%

ROE

ACUT

-21712.9%

DYAI

-35086.0%

FCF Yield %

DYAI

-45.8%

ACUT

-50.9%

52-Week Performance

DYAI

-60.7%

ACUT

-67.3%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

DYAI

Dyadic International Inc

Market Cap

ACUT$2M

DYAI$16M

Enterprise Value

ACUT$2M

DYAI$20M

Price

ACUT$0.15

DYAI$0.44

P/E Ratio

ACUTN/A

DYAIN/A

P/S Ratio

ACUT0.00x

DYAI4.26x

EV/Sales

ACUT0.00x

DYAI5.21x

EV/EBITDA

ACUT0.00x

DYAI75.44x

P/B Ratio

ACUT2.97x

DYAI14.82x

P/FCF Ratio

ACUTN/A

DYAIN/A

EV/FCF

ACUT-2.01x

DYAI-2.67x

PEG Ratio

ACUTN/A

DYAIN/A

Forward P/E (NTM)

ACUTN/A

DYAIN/A

Forward P/S (NTM)

ACUTN/A

DYAI2.15x

Revenue (TTM)

ACUT$0

DYAI$4M

Revenue Growth (YoY)

ACUTN/A

DYAI-8.1%

Forward Rev Growth

ACUT0.0%

DYAI91.1%

Gross Margin (TTM)

ACUT0.0%

DYAI16.2%

Operating Margin (TTM)

ACUT0.0%

DYAI0.0%

EBITDA Margin (TTM)

ACUT0.0%

DYAI-194.5%

Net Margin (TTM)

ACUT0.0%

DYAI-200.5%

FCF Margin (TTM)

ACUTN/A

DYAI-194.7%

Net Income (TTM)

ACUT$-2M

DYAI$-8M

FCF (TTM)

ACUT$-1M

DYAI$-7M

EPS (TTM)

ACUT-$0.10

DYAI-$0.21

ROE (TTM)

ACUT-21712.9%

DYAI-35086.0%

ROA (TTM)

ACUT-10530.0%

DYAI-8477.0%

ROIC (TTM)

ACUT-179413.5%

DYAI-8444.0%

Cash

ACUT$13K

DYAI$1M

Debt

ACUT$63K

DYAI$5M

Net Cash/Debt

ACUT$-50K

DYAI$-4M

Current Ratio (TTM)

ACUT0.02x

DYAI1.65x

Quick Ratio (TTM)

ACUT0.00x

DYAI1.54x

Debt/Equity (TTM)

ACUT0.27x

DYAI4.08x

Debt/Assets (TTM)

ACUT0.0%

DYAI0.0%

Interest Coverage (TTM)

ACUTN/A

DYAIN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

DYAI0.00x

Beta

ACUT1.88

DYAI1.09

52W Performance

ACUT-67.3%

DYAI-60.7%

YTD Performance

ACUT-75.6%

DYAI-52.8%

% from 52W High

ACUT-93.7%

DYAI-72.2%

% from 52W Low

ACUT26.0%

DYAI30.6%

Asset Turnover (TTM)

ACUT0.00x

DYAI0.42x

FCF Yield (TTM)

ACUT-50.9%

DYAI-45.8%

Earnings Yield (TTM)

ACUT-69.8%

DYAI-47.1%

Dividend Yield (TTM)

ACUTN/A

DYAIN/A

Rule of 40

ACUT0.0

DYAI-202.8

EV/GP/RG

ACUTN/A

DYAI0.30

Ticker research

View ACUT research View DYAI research

Metric	ACUT Accustem Sciences Inc	DYAI Dyadic International Inc
Market & Valuation
Market Cap	$2M	$16M
Enterprise Value	$2M	$20M
Price	$0.15	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.26x
EV/Sales	0.00x	5.21x
EV/EBITDA	0.00x	75.44x
P/B Ratio	2.97x	14.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-2.67x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.15x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	-8.1%
Forward Rev Growth	0.0%	91.1%
Profitability
Gross Margin (TTM)	0.0%	16.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-194.5%
Net Margin (TTM)	0.0%	-200.5%
FCF Margin (TTM)	N/A	-194.7%
Net Income (TTM)	$-2M	$-8M
FCF (TTM)	$-1M	$-7M
EPS (TTM)	-$0.10	-$0.21
ROE (TTM)	-21712.9%	-35086.0%
ROA (TTM)	-10530.0%	-8477.0%
ROIC (TTM)	-179413.5%	-8444.0%
Financial Health
Cash	$13K	$1M
Debt	$63K	$5M
Net Cash/Debt	$-50K	$-4M
Current Ratio (TTM)	0.02x	1.65x
Quick Ratio (TTM)	0.00x	1.54x
Debt/Equity (TTM)	0.27x	4.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	1.09
52W Performance	-67.3%	-60.7%
YTD Performance	-75.6%	-52.8%
% from 52W High	-93.7%	-72.2%
% from 52W Low	26.0%	30.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.42x
FCF Yield (TTM)	-50.9%	-45.8%
Earnings Yield (TTM)	-69.8%	-47.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-202.8
EV/GP/RG	N/A	0.30
Ticker research	View ACUT research	View DYAI research